Cholecystokinin protects rats against sepsis induced by Staphylococcus aureus

Medical Microbiology and Immunology

Volumn 203, Issue 3, 2014, Pages 165-176

  Zuelli, Fabiana Maria Das Graças Corsi ^a   Cárnio, Evelin Capellari ^a   Saia, Rafael Simone ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

CCK; Cell migration; Macrophage; Neutrophil; Nitric oxide; Proglumide

Indexed keywords

CHOLECYSTOKININ; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PERITONEAL DIALYSIS FLUID; PROGLUMIDE; TUMOR NECROSIS FACTOR ALPHA; IMMUNOLOGIC FACTOR;

ADOPTIVE TRANSFER; ADULT; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL COUNT; BACTERICIDAL ACTIVITY; CARDIOVASCULAR FUNCTION; CELL MIGRATION; CONTROLLED STUDY; GRAM POSITIVE BACTERIUM; GRAM POSITIVE INFECTION; IMMUNOREGULATION; IN VITRO STUDY; INFLAMMATION; INNATE IMMUNITY; LEUKOCYTE; MACROPHAGE MIGRATION; MALE; NEUTROPHIL; NONHUMAN; PERITONEAL CAVITY; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RAT; SEPSIS; STAPHYLOCOCCUS AUREUS; ANIMAL; BACTERIAL LOAD; BLOOD; BODY FLUID; DRUG EFFECTS; IMMUNOLOGY; MICROBIOLOGY; STAPHYLOCOCCAL INFECTIONS; WISTAR RAT;

ANIMALS; BACTERIAL LOAD; BLOOD; BODY FLUIDS; CHOLECYSTOKININ; IMMUNOLOGIC FACTORS; INTERLEUKIN-10; MALE; PERITONEAL CAVITY; RATS, WISTAR; SEPSIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84902260958     PISSN: 03008584     EISSN: 14321831     Source Type: Journal    
DOI: 10.1007/s00430-014-0328-3     Document Type: Article

References (53)

1. Calandra T, Cohen J (2005) The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med 33(7):1538-1548 (Pubitemid 40980610)
2. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International sepsis definitions conference. Intensive Care Med 29(4):530-538. doi:10.1007/s00134-003-1662-x (Pubitemid 36523666)
3. Naber CK (2009) Staphylococcus aureus bacteremia: epidemiology, pathophysiology, and management strategies. Clin Infect Dis 48(Suppl 4):S231-S237. doi:10.1086/598189
4. Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348(16):1546-1554. doi:10.1056/NEJMoa022139 (Pubitemid 36437931)
5. Marra AR, Camargo LF, Pignatari AC, Sukiennik T, Behar PR, Medeiros EA, Ribeiro J, Girao E, Correa L, Guerra C, Brites C, Pereira CA, Carneiro I, Reis M, de Souza MA, Tranchesi R, Barata CU, Edmond MB (2011) Nosocomial bloodstream infections in Brazilian hospitals: analysis of 2,563 cases from a prospective nationwide surveillance study. J Clin Microbiol 49(5):1866-1871. doi:10.1128/JCM.00376-11
6. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D (2006) Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 34(2):344-353 (Pubitemid 43145611)
7. Miyake K (2004) Innate recognition of lipopolysaccharide by Toll-like receptor 4-MD-2. Trends Microbiol 12(4):186-192. doi:10.1016/j.tim.2004.02.009
8. Verdrengh M, Tarkowski A (1997) Role of neutrophils in experimental septicemia and septic arthritis induced by Staphylococcus aureus. Infect Immun 65(7):2517-2521 (Pubitemid 27264071)
9. Ulloa L, Tracey KJ (2005) The "cytokine profile": a code for sepsis. Trends Molec Med 11(2):56-63. doi:10.1016/j.molmed.2004.12.007
10. Bozza FA, Salluh JI, Japiassu AM, Soares M, Assis EF, Gomes RN, Bozza MT, Castro-Faria-Neto HC, Bozza PT (2007) Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care 11(2):R49. doi:10.1186/cc5783
11. Chandra R, Liddle RA (2007) Cholecystokinin. Curr Opin Endocrinol Diabetes Obes 14(1):63-67. doi:10.1097/MED.0b013e3280122850 (Pubitemid 46375391)
12. Dufresne M, Seva C, Fourmy D (2006) Cholecystokinin and gastrin receptors. Physiol Rev 86(3):805-847. doi:10.1152/physrev.00014.2005 (Pubitemid 44033383)
13. Sacerdote P, Wiedermann CJ, Wahl LM, Pert CB, Ruff MR (1991) Visualization of cholecystokinin receptors on a subset of human monocytes and in rat spleen. Peptides 12(1):167-176
14. Cuq P, Gross A, Terraza A, Fourmy D, Clerc P, Dornand J, Magous R (1997) mRNA s encoding CCKB but not CCKA receptors are expressed in human T lymphocytes and Jurkat lymphoblastoid cells. Life Sci 61(5):543-555 (Pubitemid 27301387)
15. Xu SJ, Gao WJ, Cong B, Yao YX, Gu ZY (2004) Effect of lipopolysaccharide on expression and characterization of cholecystokinin receptors in rat pulmonary interstitial macrophages. Acta Pharmacol Sin 25(10):1347-1353 (Pubitemid 39361808)
16. Cong B, Li SJ, Yao YX, Zhu GJ, Ling YL (2002) Effect of cholecystokinin octapeptide on tumor necrosis factor alpha transcription and nuclear factor-kappaB activity induced by lipopolysaccharide in rat pulmonary interstitial macrophages. World J Gastroenterol 8(4):718-723 (Pubitemid 34918670)
17. Saia RS, Bertozi G, Mestriner FL, Antunes-Rodrigues J, Queiroz Cunha F, Carnio EC (2013) Cardiovascular and inflammatory response to cholecystokinin during endotoxemic shock. Shock 39(1):104-113. doi:10.1097/SHK.0b013e3182793e2e
18. Li S, Ni Z, Cong B, Gao W, Xu S, Wang C, Yao Y, Ma C, Ling Y (2007) CCK-8 inhibits LPS-induced IL-1beta production in pulmonary interstitial macrophages by modulating PKA, p38, and NF-kappaB pathway. Shock 27(6):678-686. doi:10.1097/shk.0b013e3180ze26dd (Pubitemid 46795130)
19. De la Fuente M, Campos M, Del Rio M, Hernanz A (1995) Inhibition of murine peritoneal macrophage functions by sulfated cholecystokinin octapeptide. Regul Pept 55(1):47-56
20. Carrasco M, Del Rio M, Hernanz A, De la Fuente M (1997) Inhibition of human neutrophil functions by sulfated and nonsulfated cholecystokinin octapeptides. Peptides 18(3):415-422 (Pubitemid 27224374)
21. Bozkurt A, Cakir B, Ercan F, Yegen BC (2003) Anti-inflammatory effects of leptin and cholecystokinin on acetic acid-induced colitis in rats: role of capsaicin-sensitive vagal afferent fibers. Regul Pept 116(1-3):109-118 (Pubitemid 37355978)
22. Zhao XY, Ling YL, Li YG, Meng AH, Xing HY (2005) Cholecystokinin octapeptide improves cardiac function by activating cholecystokinin octapeptide receptor in endotoxic shock rats. World J Gastroenterol 11(22):3405-3410
23. Miyamoto S, Shikata K, Miyasaka K, Okada S, Sasaki M, Kodera R, Hirota D, Kajitani N, Takatsuka T, Kataoka HU, Nishishita S, Sato C, Funakoshi A, Nishimori H, Uchida HA, Ogawa D, Makino H (2012) Cholecystokinin plays a novel protective role in diabetic kidney through anti-inflammatory actions on macrophage: anti-inflammatory effect of cholecystokinin. Diabetes 61(4):897-907. doi:10.2337/db11-0402
24. Alvarez A, Ibiza S, Hernandez C, Alvarez-Barrientos A, Esplugues JV, Calatayud S (2006) Gastrin induces leukocyte-endothelial cell interactions in vivo and contributes to the inflammation caused by Helicobacter pylori. FASEB J 20(13):2396-2398. doi:10.1096/fj.05-5696fje
25. Saia RS, Oliveira-Pelegrin GR, da Silva ME, Aguila FA, Antunes-Rodrigues J, Rocha MJ, Carnio EC (2011) Neonatal endotoxin exposure changes neuroendocrine, cardiovascular function and mortality during polymicrobial sepsis in adult rats. Regul Pept 169(1-3):21-30. doi:10.1016/j.regpep.2011.04. 009
26. Sidiq T, Khajuria A, Suden P, Sharma R, Singh S, Suri KA, Satti NK, Johri RK (2011) Possible role of macrophages induced by an irridoid glycoside (RLJ-NE-299A) in host defense mechanism. Int Immunopharmacol 11(1):128-135. doi:10.1016/j.intimp.2010.10.017
27. Crosara-Alberto DP, Darini AL, Inoue RY, Silva JS, Ferreira SH, Cunha FQ (2002) Involvement of NO in the failure of neutrophil migration in sepsis induced by Staphylococcus aureus. Br J Pharmacol 136(5):645-658. doi:10.1038/sj.bjp.0704734 (Pubitemid 34785707)
28. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39(3):309-317. doi:10.1086/421946 (Pubitemid 39050477)
29. Cosgrove SE (2006) The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis 42(Suppl 2):S82-S89. doi:10.1086/499406
30. Weiland TJ, Kent S, Voudouris NJ, Shulkes A (2005) The effect of lipopolysaccharide on cholecystokinin in murine plasma and tissue. Peptides 26(3):447-455. doi:10.1016/j.peptides.2004.10.006 (Pubitemid 40126702)
31. Bercik P, Verdu EF, Foster JA, Lu J, Scharringa A, Kean I, Wang L, Blennerhassett P, Collins SM (2009) Role of gut-brain axis in persistent abnormal feeding behavior in mice following eradication of Helicobacter pylori infection. Am J Physiol 296(3):R587-R594. doi:10.1152/ajpregu.90752.2008
32. Ovington KS, Bacarese-Hamilton AJ, Bloom SR (1985) Nippostrongylus brasiliensis: changes in plasma levels of gastrointestinal hormones in the infected rat. Exp Parasitol 60(3):276-284
33. Ling YL, Meng AH, Zhao XY, Shan BE, Zhang JL, Zhang XP (2001) Effect of cholecystokinin on cytokines during endotoxic shock in rats. World J Gastroenterol 7(5):667-671
34. Grivennikov SI, Tumanov AV, Liepinsh DJ, Kruglov A, Marakusha BI, Shakhov AN, Murakami T, Drutskaya LN, Forster I, Clausen BE, Tessarollo L, Ryffel B, Kuprash DV, Nedospasov SA (2005) Distinct and nonredundant in vivo functions of TNF produced by t cells and macrophages/neutrophils: protective and deleterious effects. Immunity 22(1):93-104. doi:10.1016/j.immuni.2004.11.016 (Pubitemid 40143454)
35. van den Berg S, Laman JD, Boon L, ten Kate MT, de Knegt GJ, Verdijk RM, Verbrugh HA, Nouwen JL, Bakker-Woudenberg IA (2013) Distinctive cytokines as biomarkers predicting fatal outcome of severe Staphylococcus aureus bacteremia in mice. PLoS ONE 8(3):e59107. doi:10.1371/journal.pone.0059107
36. van der Poll T, Marchant A, Buurman WA, Berman L, Keogh CV, Lazarus DD, Nguyen L, Goldman M, Moldawer L, Lowry SF (1995) Endogenous IL-10 protects mice from death during septic peritonitis. J Immunol 155(11):5397-5401 (Pubitemid 3015364)
37. Howard M, Muchamuel T, Andrade S, Menon S (1993) Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 177(4):1205-1208 (Pubitemid 23097411)
38. Friedman G, Jankowski S, Marchant A, Goldman M, Kahn RJ, Vincent JL (1997) Blood interleukin 10 levels parallel the severity of septic shock. J Crit Care 12(4):183-187 (Pubitemid 28051044)
39. Berg DJ, Kuhn R, Rajewsky K, Muller W, Menon S, Davidson N, Grunig G, Rennick D (1995) Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest 96(5):2339-2347. doi:10.1172/JCI118290
40. Latifi SQ, O'Riordan MA, Levine AD (2002) Interleukin-10 controls the onset of irreversible septic shock. Infect Immun 70(8):4441-4446 (Pubitemid 34790955)
41. Alves-Filho JC, Spiller F, Cunha FQ (2010) Neutrophil paralysis in sepsis. Shock 34(Suppl 1):15-21. doi:10.1097/SHK.0b013e3181e7e61b
42. Benjamim CF, Ferreira SH, Cunha FQ (2000) Role of nitric oxide in the failure of neutrophil migration in sepsis. J Infect Dis 182(1):214-223. doi:10.1086/315682 (Pubitemid 30497807)
43. Tavares-Murta BM, Cunha FQ, Ferreira SH (1998) The intravenous administration of tumor necrosis factor alpha, interleukin 8 and macrophage-derived neutrophil chemotactic factor inhibits neutrophil migration by stimulating nitric oxide production. Br J Pharmacol 124(7):1369-1374. doi:10.1038/sj.bjp.0701965 (Pubitemid 28360558)
44. Ajuebor MN, Das AM, Virag L, Flower RJ, Szabo C, Perretti M (1999) Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: evidence for an inhibitory loop involving endogenous IL-10. J Immunol 162(3):1685-1691 (Pubitemid 29307046)
45. Schroder JM (2000) Chemoattractants as mediators of neutrophilic tissue recruitment. Clin Dermatol 18(3):245-263
46. Henderson RB, Hobbs JA, Mathies M, Hogg N (2003) Rapid recruitment of inflammatory monocytes is independent of neutrophil migration. Blood 102(1):328-335. doi:10.1182/blood-2002-10-3228 (Pubitemid 36759673)
47. Cailhier JF, Partolina M, Vuthoori S, Wu S, Ko K, Watson S, Savill J, Hughes J, Lang RA (2005) Conditional macrophage ablation demonstrates that resident macrophages initiate acute peritoneal inflammation. J Immunol 174(4):2336-2342 (Pubitemid 40223983)
48. Issekutz AC, Issekutz TB (1993) Quantitation and kinetics of blood monocyte migration to acute inflammatory reactions, and IL-1 alpha, tumor necrosis factor-alpha, and IFN-gamma. J Immunol 151(4):2105-2115 (Pubitemid 23235683)
49. Sacerdote P, Ruff MR, Pert CB (1988) Cholecystokinin and the immune system: receptor-mediated chemotaxis of human and rat monocytes. Peptides 9(Suppl 1):29-34
50. de la Fuente M, Drummond J, del Rio M, Carrasco M, Hernanz A (1996) Modulation of murine peritoneal macrophage functions by gastrin. Peptides 17(2):219-224 (Pubitemid 26124401)
51. Pierangeli S, Sonnenfeld G (1993) Treatment of murine macrophages with murine interferon-gamma and tumour necrosis factor-alpha enhances uptake and intracellular killing of Pseudomonas aeruginosa. Clin Exp Immunol 93(2):165-171 (Pubitemid 23238021)
52. Nizet V (2007) Understanding how leading bacterial pathogens subvert innate immunity to reveal novel therapeutic targets. J Allergy Clin Immunol 120(1):13-22. doi:10.1016/j.jaci.2007.06.005
53. McMillen MA, Ferrara A, Adrian TE, Margolis DS, Schaefer HC, Zucker KA (1995) Cholecystokinin effect on human lymphocyte ionized calcium and mitogenesis. J Surg Res 58(2):149-158. doi:10.1006/jsre1995.1024